CPH 15.6% 18.5¢ creso pharma limited

CPH the most undervalued stock on the ASX - based on market comparisons

  1. 12 Posts.
    lightbulb Created with Sketch. 12
    Based on comparisons to a number of almost identical or very similar psychedelics companies' CPH are unbelievably undervalued.

    In the weeks following Mind Medicine announcing they were entering into the psychedelics market, they added nearly 1 Billion Dollars to their market cap... (share price chart below) Their Psychedelics research is seemingly at the same or a very similar level to that of CPH.

    Other companies include Compass Pathways (1.9B market cap) and HAVN Life Sciences (200M market cap) to just name a few among many many more.

    Its only a matter of time before everyone wakes up and realises CPH is the most undervalued stock on the ASX. If you think about it in terms of if Creso were to rise 1000% just like mind med the share price would be $2.... having now settled at around the $280 mark that is still a 600% rise which if you applied that to CPH their share price would be $1,2... This is just one of so many examples showing market comparisons which illustrate the real global market value of psychedelics.

watchlist Created with Sketch. Add CPH (ASX) to my watchlist
(20min delay)
Mkt cap ! $203.8M
Open High Low Value Volume
16.5¢ 19.5¢ 16.5¢ $7.733M 42.75M

Buyers (Bids)

No. Vol. Price($)
5 391199 18.5¢

Sellers (Offers)

Price($) Vol. No.
19.0¢ 495500 6
View Market Depth
Last trade - 16.10pm 11/06/2021 (20 minute delay) ?
0.025 ( 15.9 %)
Open High Low Volume
16.5¢ 19.5¢ 16.5¢ 25004434
Last updated 15.59pm 11/06/2021 (live) ?
CPH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.